Myeloperoxidase (MPO) Blood Test: A New Marker for Cardiovascular Disease Risk

Health · 5 October 2026 · By AROGYOS Health Team

Discover how the myeloperoxidase (MPO) blood test predicts heart disease risk, its role as a cardiovascular biomarker, and actionable steps to lower MPO levels for longevity.

A 2023 meta‑analysis of over 30,000 participants found that people with myeloperoxidase (MPO) levels in the top quartile had a 2.5‑fold higher risk of heart attack over five years compared to those with low MPO, even after adjusting for LDL cholesterol. This striking statistic signals that MPO is fast becoming a must‑track metric for anyone serious about heart health and longevity.

Myeloperoxidase (MPO) Test: A Cutting‑Edge Cardiovascular Biomarker

What is MPO and How Is It Measured?

Myeloperoxidase is an enzyme released by activated neutrophils and monocytes during the immune response. It catalyzes the production of hypochlorous acid, a potent oxidative stress agent that can damage arterial walls. The MPO blood test measures the concentration of this enzyme in plasma, typically reported in ng/mL. Modern immunoassays provide results within a day, allowing you to track your biomarkers free on AROGYOS(https://arogyos.com/signup) and spot trends early.

Why MPO Predicts Heart Disease Better Than Traditional Lipids

Unlike LDL‑C, which only reflects the amount of circulating cholesterol, MPO directly signals ongoing inflammation and endothelial injury. Studies show that elevated MPO predicts plaque rupture and acute coronary events even when LDL is optimal. When combined with high‑sensitivity C‑reactive protein (hsCRP), MPO improves risk stratification, echoing the AROGYOS insight: "Chronic inflammation accelerates aging: hsCRP above 3 mg/L doubles your biological aging rate. Turmeric, omega-3, and cutting refined sugar are the fastest ways to lower systemic inflammation."

Interpreting Your MPO Results

Typical reference ranges are 0‑100 ng/mL, but labs vary. - < 40 ng/mL – low‑risk zone; maintain current lifestyle. - 40‑80 ng/mL – moderate risk; consider dietary tweaks and targeted supplements. - > 80 ng/mL – high risk; discuss anti‑inflammatory strategies with your clinician. Understanding where you fall helps you decide whether to focus on diet, exercise, or medical interventions.

Integrating MPO with Other Biomarkers

MPO shines brightest when viewed alongside a panel of cardiovascular biomarkers such as LDL‑C, triglycerides, hsCRP, and lipoprotein(a). The AROGYOS platform lets you analyse your lab report instantly(https://arogyos.com) and visualize how each marker moves over time. For biohackers, pairing MPO data with your biological age metrics—see our guide on What is Biological Age—creates a holistic picture of heart health versus overall aging.

Lifestyle Strategies to Lower MPO Levels

1. Anti‑inflammatory diet – Emphasise oily fish, leafy greens, nuts, and extra‑virgin olive oil. Avoid processed meats and trans fats.
2. Targeted supplements – Vitamin C, N‑acetylcysteine, and magnesium have modest MPO‑lowering effects.
3. Regular aerobic exercise – 150 minutes/week of moderate activity reduces neutrophil activation.
4. Stress management – Mindfulness and adequate sleep blunt the sympathetic surge that spikes MPO.
5. Gut health – Probiotic‑rich foods support immune regulation, indirectly curbing MPO release.

By monitoring MPO, you gain a window into the invisible battle between oxidative stress and vascular repair. Pair this insight with AROGYOS’s comprehensive health‑optimization tools, and you’re equipped to make data‑driven decisions that extend both lifespan and healthspan.

For more on this from a clinical source, see American Heart Association.